©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 109130
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.109130
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.109130
Figure 1 Flowchart illustrating the process of study identification, screening, and inclusion in the analysis.
The diagram outlines the number of records identified, screened, excluded, and ultimately included based on predefined eligibility criteria. HLA: Human leukocyte antigen.
- Citation: Li XG, Qi MY, Li X, Ping F. Exogenous insulin-associated autoimmunity and the emergence of double diabetes in type 2 diabetes. World J Diabetes 2025; 16(9): 109130
- URL: https://www.wjgnet.com/1948-9358/full/v16/i9/109130.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i9.109130